Literature DB >> 6204380

Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus.

J Sodroski, R Patarca, D Perkins, D Briggs, T H Lee, M Essex, J Coligan, F Wong-Staal, R C Gallo, W A Haseltine.   

Abstract

The sequence of the envelope glycoprotein gene of type II human T lymphotropic virus (HTLV) is presented. The predicted amino acid sequence is similar to that of the corresponding protein of HTLV type I, in that the proteins share the same amino acids at 336 of 488 residues, and 68 of the 152 differences are of a conservative nature. The overall structural similarity of these proteins provides an explanation for the antigenic cross-reactivity observed among diverse members of the HTLV retrovirus family by procedures that assay for the viral envelope glycoprotein, for example, membrane immunofluorescence.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6204380     DOI： 10.1126/science.6204380

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  18 in total

1.  Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.

Authors:  L D Papsidero; R P Dittmer; L Vaickus; B J Poiesz
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor.

Authors:  D S Kohtz; A Altman; J D Kohtz; S Puszkin
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.

Authors:  A Pinter; R Kopelman; Z Li; S C Kayman; D A Sanders
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

7.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.

Authors:  E Thomas; J Overbaugh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Computer analysis of human immunodeficiency virus-1 envelope glycoprotein: functional topogenic domains as signals for transfer and cleavage.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1991-10       Impact factor: 2.332

10.  Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus.

Authors:  T H Lee; J E Coligan; M F McLane; J G Sodroski; M Popovic; F Wong-Staal; R C Gallo; W Haseltine; M Essex
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.